NumFin

ResMed Inc.

Sümbol: RMD

NYSE

218.15

USD

Turuhind täna

  • 33.4514

    P/E suhe

  • 11.6602

    PEG suhe

  • 32.05B

    MRK Cap

  • 0.01%

    DIV tootlus

ResMed Inc. (RMD) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete ResMed Inc. (RMD) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1165.686 M, mis on 0.272 % gowth. Kogu perioodi keskmine brutokasum on 685.376 M, mis on 0.262 %. Keskmine brutokasumi suhtarv on 0.612 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 0.152 %, mis on võrdne 0.363 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes ResMed Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.325. Käibevara valdkonnas on RMD aruandlusvaluutas 2367.83. Märkimisväärne osa neist varadest, täpsemalt 227.891, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.167%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 1548.087 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.722%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 4129.903 aruandlusvaluutas. Selle aspekti aastane muutus on 0.229%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 704.909, varude hind on 998.01 ja firmaväärtus 2770.3, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 552.34. Kontovõlad ja lühiajalised võlad on vastavalt 150.76 ja 31.82. Koguvõlg on 1579.91, netovõlg on 1352.02. Muud lühiajalised kohustused moodustavad 437.88, mis lisandub kohustuste kogusummale 2621.8. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

balance-sheet.row.cash-and-short-term-investments

885.15227.9273.7295.3
463.2
147.1
188.7
821.9
731.4
717.2
905.7
876
809.5
735.3
488.8
415.6
321.1
277.7
219.5
142.2
140.9
121
92.8
102.8
22
16.7
15.5
9.1
5.5
3.3
3.7
1.7

balance-sheet.row.short-term-investments

53.412.49.20
0
0
0
0
0
0
0
0
0
0
0
0
0
19.9
0
0
12
6.5
20
62.6
3.7
5.6
0
0
0
0
0
0

balance-sheet.row.net-receivables

2944.23704.9576614.3
474.6
528.5
483.7
450.5
382.1
362.6
359.6
318.3
285.4
283.6
232.2
214.2
209.3
175.8
138.1
104
67.2
56.7
46.2
32.2
24.7
17.9
13.2
7.8
6.3
3.8
2.4
1.5

balance-sheet.row.inventory

3718.92998743.9457
416.9
349.6
268.7
268.3
224.5
246.9
165.4
145.8
174.4
200.8
185.6
157.4
158.3
157.2
116.2
89.1
55.8
49.4
41.2
30
15.8
10.7
7.6
5.8
6.1
4.4
1
1

balance-sheet.row.other-current-assets

1528.25437337.9208.2
168.7
120.1
124.6
103.2
81.7
117.5
125.5
108.6
72.2
72.8
78.7
66
50.6
58.1
36.4
25
13.9
14.8
13.5
12.9
6.7
5.5
10.3
21.7
19.9
21.5
1.4
0.3

balance-sheet.row.total-current-assets

9401.792367.81931.51574.8
1523.5
1145.4
1065.7
1644
1419.7
1444.2
1556.2
1448.8
1361.2
1292.5
985.3
853.3
739.2
668.8
510.3
360.2
277.8
241.9
193.7
177.9
69.2
50.8
46.6
44.4
37.8
33
8.5
4.5

balance-sheet.row.property-plant-equipment-net

2715.24665.8630.5592.1
535.7
387.5
386.6
394.2
384.3
387.8
434.3
411.4
434.4
462.1
387.1
377.6
357.1
310.6
245.4
174.2
147.3
104.7
79.3
55.1
36.6
29.3
11.1
4.9
3.3
2
0.8
0.5

balance-sheet.row.goodwill

11280.292770.31936.41927.9
1890.3
1856.4
1068.9
1064.9
1059.2
264.3
289.3
274.8
256.2
235.5
198.6
213.2
234.6
206.8
195.6
181.1
106.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

2144.82552.3345.9392.6
448.2
522
215.2
261.8
299.8
47.1
45.2
49.6
54.8
47.9
30.9
35
46.8
46.6
48.9
230.5
110.9
105.9
95.2
49.3
7
7.3
5.9
4.8
4.5
0.2
0.1
0.1

balance-sheet.row.goodwill-and-intangible-assets

13425.113322.62282.42320.5
2338.5
2378.4
1284.1
1326.7
1359.1
311.4
334.5
324.5
311
283.4
229.6
248.2
281.4
253.4
244.5
230.5
110.9
105.9
95.2
49.3
7
7.3
5.9
4.8
4.5
0.2
0.1
0.1

balance-sheet.row.long-term-investments

-325.51-133-251.5-240.8
-189.7
-196.5
-327.5
-103.6
-95.9
-40.9
-36
-26
-23.5
0
0
4.3
4.6
0
-26.6
-15.2
-7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

1116.87133251.5240.8
189.7
196.5
327.5
103.6
95.9
40.9
36
26
23.5
18.9
19
19.4
16.2
9.2
26.6
15.2
7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

878.65395.4251.5240.8
189.7
196.5
327.5
103.6
95.9
40.9
36
26
31.3
12
5.3
5.3
7.5
10.1
7.1
9.3
8.2
7.1
8
5.9
2.9
2.5
1
0.8
1.3
0.1
0.2
0.1

balance-sheet.row.total-non-current-assets

17810.364383.93164.43153.4
3063.9
2962.3
1998.2
1824.5
1839.2
740.1
804.8
761.9
776.7
776.5
641.1
654.7
666.8
583.2
496.9
413.9
266.3
217.7
182.5
110.2
46.4
39.1
18
10.5
9.1
2.3
1.1
0.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

27212.146751.75095.94728.1
4587.4
4107.7
3063.9
3468.5
3258.9
2184.3
2361
2210.7
2137.9
2068.9
1626.4
1508
1406
1252
1007.2
774.1
544.2
459.6
376.2
288.1
115.6
89.9
64.6
54.9
46.9
35.3
9.6
5.2

balance-sheet.row.account-payables

707.64150.8159.2138
135.8
115.7
92.7
92.8
92.6
81.1
85.4
60.7
55
55.2
57.5
48.3
56.3
53
45
34.4
18.6
19.4
11.6
8
5.9
4.8
3.8
2.6
2.4
2.6
1.5
0.8

balance-sheet.row.short-term-debt

131.5631.831.835.6
33.3
12
11.5
215
300
148.1
0
300
0.1
0.2
94.2
67.5
43.9
28.4
4.9
115.4
22.6
19.1
0
0
0
0
0.2
0.3
0.3
0
0
0.1

balance-sheet.row.tax-payables

240.6672.244.9308
64.8
73.2
160.4
29.1
39.2
16.3
10.4
30.1
27.8
3.9
22.7
57
3.8
3.4
22.8
22
8.5
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

5366.511548.1885.8758.1
1266
1258.9
270
1078.6
875
300.6
300.8
0.8
250.8
100
27.5
94.2
93.8
87.6
116.2
58.9
113.3
113.3
123.3
150
0
0
0
0.3
0.6
0.8
0.4
0.2

Deferred Revenue Non Current

500.07119.295.591.5
87.3
81.1
71.6
53.2
40.3
19.3
16.4
11.9
14.4
17.2
12.8
15.2
15.7
12.5
11.5
10.9
8.8
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

354.17---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

1642.79437.9389.6628.6
335.1
339.6
346.2
0.5
196
2
141.8
168.4
156.2
108.4
103.9
124.4
66.3
102.1
63.7
56.4
10.7
5.7
37.4
25.6
15.7
13.4
9.8
7.1
4.7
3.1
2
1

balance-sheet.row.total-non-current-liabilities

6653.651863.31045.8930.7
1487.6
1479.5
493.7
1148.1
925.6
329.7
333.2
26.2
277.4
129.3
53.7
123.7
131.6
118.4
140.1
81.5
122.1
122.6
134.2
154.1
0
0.1
0
0.3
0.5
0.7
0.5
0.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

574.03138.8142.3138.4
123.1
0
0
0
0
0
0
0
0
0
0
0
0
0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

9720.092621.81735.11842.4
2090.3
2035.5
1004.9
1508.2
1564.1
597
602.7
600.2
530.2
338.2
338.9
392.8
324.2
320.8
269.1
300.1
182.7
173.2
183.3
187.7
21.6
18.3
13.8
10.3
7.9
6.4
4
2.3

balance-sheet.row.preferred-stock

0000
0
0
0.3
0.1
0
0
0.4
0
0
0
0
0.2
0.2
0.2
0
0.1
0
0
0
9.6
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2.350.60.60.6
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.3
0.3
0.3
0.3
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0

balance-sheet.row.retained-earnings

17964.7842533613.73079.6
2833
2436.4
2432.3
2316.2
2160.3
1976
1780.4
1576.6
1366.7
1111.9
884.9
694.8
548.3
437
370.7
282.4
217.7
160.4
114.6
77.1
65.5
43.3
27.2
16.6
9.1
4.6
1.8
0.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

-1066.33-272.5-312.7-193.5
-284
-253
-224.3
-189.1
-222.7
-173.5
151.6
92.1
236.5
324.4
86.4
105.8
207.8
115.8
55.1
52.9
41.3
29.9
-8.1
-29.6
-13.2
-5.4
-5.4
-3.5
-2.2
0
0
0

balance-sheet.row.other-total-stockholders-equity

591.25148.859.2-1.1
-52.6
-111.8
-149.9
-167.5
-243.4
-215.8
-174.7
-58.8
3.9
293.8
316
314.1
325.1
378
312.1
138.5
102.4
96
86.3
43
41.5
33.6
29
31.5
32.1
24.3
3.8
2.2

balance-sheet.row.total-stockholders-equity

17492.054129.93360.82885.7
2497
2072.2
2059
1960.3
1694.8
1587.3
1758.2
1610.5
1607.6
1730.7
1287.5
1115.2
1081.8
931.2
738.1
474.1
361.5
286.4
192.9
100.4
94
71.6
50.8
44.6
39
28.9
5.6
2.9

balance-sheet.row.total-liabilities-and-stockholders-equity

27212.146751.75095.94728.1
4587.4
4107.7
3063.9
3468.5
3258.9
2184.3
2361
2210.7
2137.9
2068.9
1626.4
1508
1406
1252
1007.2
774.1
544.2
459.6
376.2
288.1
115.6
89.9
64.6
54.9
46.9
35.3
9.6
5.2

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

17492.054129.93360.82885.7
2497
2072.2
2059
1960.3
1694.8
1587.3
1758.2
1610.5
1607.6
1730.7
1287.5
1115.2
1081.8
931.2
738.1
474.1
361.5
286.4
192.9
100.4
94
71.6
50.8
44.6
39
28.9
5.6
2.9

balance-sheet.row.total-liabilities-and-total-equity

27212.14---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

-325.51-133-251.5-240.8
-189.7
-196.5
-327.5
-103.6
-95.9
-40.9
-36
-26
-23.5
0
0
4.3
4.6
19.9
-26.6
-15.2
12
6.5
20
62.6
3.7
5.6
0
0
0
0
0
0

balance-sheet.row.total-debt

5634.391579.9917.5793.7
1299.3
1270.9
281.5
1078.6
1175
300.6
300.8
300.8
250.8
100.2
121.7
161.7
137.7
116
121.1
174.4
113.3
113.3
123.3
150
0
0
0.2
0.6
0.9
0.8
0.4
0.3

balance-sheet.row.net-debt

4749.241352643.8498.4
836.1
1123.7
92.8
256.7
443.6
-416.7
-604.9
-575.3
-558.7
-635.1
-367.1
-253.9
-183.4
-141.8
-98.5
32.2
-15.7
-1.2
50.4
109.9
-18.3
-11.1
-15.3
-8.5
-4.6
-2.5
-3.3
-1.4

Rahavoogude aruanne

ResMed Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 1.867 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 49.14, mis tähistab 0.341 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 1070, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus -21.418 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 31.34 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -1159845000.000. See on 4.045 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 197.56, 0, -405, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -258.28 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -32.99, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

cash-flows.row.net-income

958.38897.6779.4474.5
621.7
404.6
315.6
342.3
352.4
352.9
345.3
307.1
254.8
227
190.1
146.4
110.3
66.3
88.2
64.8
57.3
45.7
37.5
11.6
22.2
16.1
10.6
7.5
4.5
2.8
1.2
0.8

cash-flows.row.depreciation-and-amortization

216.65197.6193.8191.5
181.4
150.8
120
112.2
86.8
73.1
73.5
78.3
85.9
10.1
61.6
54
59.5
48.1
41.6
29.1
17.9
12.6
10
8.4
6.2
4.6
3.7
2.6
1.3
0.6
0.3
0.2

cash-flows.row.deferred-income-tax

16.810.20-3.3
39.6
28.9
11.6
2
3.6
-25.7
-22.6
0
-12.6
-11.2
3.3
-26.7
8.9
-18.9
-11.9
-8
1.3
2
-6.2
-2.3
0.1
0.5
0.4
-1
0
-0.1
0.3
0.4

cash-flows.row.stock-based-compensation

78.7271.165.363.9
57.6
52.1
48.4
45.9
46.4
47.9
43.5
38.2
30.6
30.8
29.7
25.5
1.9
59.7
0
0
0
0
0
0
3
0.3
1.1
0
0
0.3
0.4
0

cash-flows.row.change-in-working-capital

-75.33-462.1-708.11.4
-97.9
-177.1
9.1
-89.9
61.7
-64.8
-42
-9.2
46
-23.5
-79.5
23.1
-64.9
-69.7
-41
-26.2
-4.5
-1.8
-8.2
-9.4
-11.4
-3.4
-9.1
0.7
-1.5
-2.8
-1.6
-0.6

cash-flows.row.account-receivables

-94.81-106.519.3-129.2
54.4
-18
-32.4
-63.6
-27.3
-28.3
-35.1
-37.3
-20.3
-30.8
-24.7
-32.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

169.55-248.8-311.7-22
-69.9
-84.2
1.5
-41.6
30.5
-99.5
-15.9
27.1
18.8
11.4
-32.3
-16.1
9.6
-30.5
-25
-22.6
-6.7
-3
-7.1
-8.1
-6
-2.9
-2.4
-0.3
0.3
-2.6
-0.8
-0.1

cash-flows.row.account-payables

-43.2431.3-247.6210.7
-23.4
-27.3
200.7
34.6
46.4
85.8
3.1
29.6
72.8
-1087.7
-695.1
-512
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-97.24-138.1-168.1-58.2
-59
-47.6
-160.7
-19.3
12.1
-22.8
5.8
-28.7
-25.3
1083.6
672.7
584.2
-74.5
-39.2
-16
-3.7
2.2
1.2
-1.1
-1.3
-5.4
-0.5
-6.7
1
-1.8
-0.2
-0.8
-0.5

cash-flows.row.other-non-cash-items

103.37-11.120.78.7
0
-0.3
0.4
1.6
-3
-0.1
-6.3
-11.6
-21.5
49.9
-17
16.5
22.2
5.6
22.1
11.4
4.7
0.8
2.5
21.2
0.1
0.1
0.1
-0.3
-0.8
-0.1
1
0.2

cash-flows.row.net-cash-provided-by-operating-activities

1198.58000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-127.27-134-156-116.8
-105.9
-77.3
-71.5
-71.5
-67.8
-71.9
-81.2
-71.8
-61.1
-75
-61.6
-114.2
-75.8
-77.6
-102.7
-39.7
-57.2
-25.6
-28.2
-27.5
-16.2
-22.5
-11.8
-4
-1.5
-1.8
-0.3
-0.3

cash-flows.row.acquisitions-net

-115.29-1012.7-42.8-39.1
-27.9
-951.4
-0.9
-7.3
-1041.4
-28.5
-3.9
-5.4
-53.3
-22.4
-10.7
-2.4
-0.9
-1.9
-10.5
-54.4
-0.2
-0.3
-13.9
-55.1
-0.6
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-22.91-32.2-37.9-21.8
-46
-47
-29.5
-6.5
-16.5
-42.7
-12.3
-3.3
-6.3
-7.9
-4.3
-2.3
-6.5
-23.6
-4.4
-403.4
-80.4
-15.2
-393.1
-82.5
-39.5
-8.8
-32
-50.1
-102.7
-27.2
0
0

cash-flows.row.sales-maturities-of-investments

9.9919.16.819.2
10.6
8.6
-9
3.3
0.5
0.9
2.3
2.5
19.1
20.9
1.1
0.2
21.4
2
2
413.6
73.4
30.8
435.9
21
38.7
6.9
44.5
49.3
105.2
6.7
0
0

cash-flows.row.other-investing-activites

-15.82000
-10.6
-8.6
9
0
-0.5
-0.9
0
0
0
7.9
17.3
9.3
23.8
-4.4
-4.2
-2.8
-2.4
-1.6
12.8
-0.5
-1
-0.5
-0.4
-0.5
-7.3
0
-0.2
0.1

cash-flows.row.net-cash-used-for-investing-activites

-269.8-1159.8-229.9-158.5
-179.9
-1075.7
-101.8
-81.9
-1125.8
-143.1
-95
-78
-101.6
-76.5
-58.3
-109.3
-37.9
-105.4
-119.9
-86.8
-66.8
-11.9
13.5
-144.6
-18.5
-24.9
0.3
-5.3
-6.3
-22.3
-0.5
-0.2

cash-flows.row.debt-repayment

-680-405-166-612
-1284
-711.7
-1146.2
-545
-283.7
-161.5
-560
-100.2
-126
-123.6
-38.4
-38.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

48.8949.147.437.8
48.2
36.7
23.3
30.2
27.7
38.8
33.4
69.2
62.5
94.7
95.2
24.9
21.6
38.3
34.4
39.4
20.3
9
9.8
7.9
6.4
2.1
1
0.2
5
20.7
1.3
0.5

cash-flows.row.common-stock-repurchased

4.661070-52.490
1190
-22.8
-53.8
450
-102.1
-160.3
-202.2
-186.3
-392.7
-163.3
-131.1
-68.6
-96.6
-2.1
0
-11
-19
-3.5
-7.9
0
0
0
0
0
0
0
-0.3
0

cash-flows.row.dividends-paid

-276.47-258.3-245.3-226.7
-225.1
-211.7
-199.5
-186.3
-168.1
-157.3
-141.5
-97.2
-270.4
-98.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.2
0

cash-flows.row.other-financing-activites

-11.67-33288-53.7
-46.4
1490.2
349.5
-11.7
1138.8
184.5
573.1
160.5
549.5
211.4
13.2
84
11.2
1.9
63.4
-3.3
0
-21.8
-23.1
131.1
0
-0.2
-0.2
-0.2
0
0.4
-0.2
-0.2

cash-flows.row.net-cash-used-provided-by-financing-activities

-914.6422.9-128.4-764.6
-317.3
580.6
-1026.7
-262.9
612.6
-255.8
-297.3
-153.9
-177.1
-79.3
-61.1
1.9
-63.8
38.1
97.8
25.2
1.3
-16.3
-21.2
139
6.4
1.9
0.8
0.3
5
21.1
0.6
0.3

cash-flows.row.effect-of-forex-changes-on-cash

-4.17-2.1-14.418.5
10.9
-5.6
-9.7
21.2
-20.6
-172.8
30.7
-104.4
-30.2
119.2
4.4
-36.9
27.1
14.5
0.4
3.8
3.4
10.6
4.7
-2.1
-1
0.4
-1.5
-0.5
0.1
21.6
0.3
-0.1

cash-flows.row.net-change-in-cash

10.02-45.8-21.6-167.9
316
-41.6
-633.2
90.5
14.2
-188.5
29.7
66.5
74.3
246.5
73.1
94.6
63.3
38.2
77.4
13.3
14.4
41.6
32.7
21.9
7.1
-4.4
6.4
4
2.3
21.1
2
1

cash-flows.row.cash-at-end-of-period

885.15227.9273.7295.3
463.2
147.1
188.7
821.9
731.4
717.2
905.7
876
809.5
735.3
488.8
415.6
321.1
257.8
219.5
142.2
128.9
114.5
72.9
40.1
18.3
11.1
15.5
9.5
5.6
24.8
3.7
1.7

cash-flows.row.cash-at-beginning-of-period

875.13273.7295.3463.2
147.1
188.7
821.9
731.4
717.2
905.7
876
809.5
735.3
488.8
415.6
321.1
257.8
219.5
142.2
128.9
114.5
72.9
40.1
18.3
11.1
15.5
9.1
5.5
3.3
3.7
1.7
0.7

cash-flows.row.operating-cash-flow

1198.58693.3351.1736.7
802.3
459.1
505
414.1
547.9
383.2
391.3
402.8
383.2
283.2
188.2
238.9
137.8
91.1
99
71.1
76.5
59.3
35.6
29.5
20.3
18.2
6.8
9.5
3.5
0.7
1.6
1

cash-flows.row.capital-expenditure

-127.27-134-156-116.8
-105.9
-77.3
-71.5
-71.5
-67.8
-71.9
-81.2
-71.8
-61.1
-75
-61.6
-114.2
-75.8
-77.6
-102.7
-39.7
-57.2
-25.6
-28.2
-27.5
-16.2
-22.5
-11.8
-4
-1.5
-1.8
-0.3
-0.3

cash-flows.row.free-cash-flow

1071.32559.3195.1619.9
696.3
381.7
433.6
342.6
480.1
311.2
310.1
331
322.1
208.2
126.6
124.7
62.1
13.6
-3.7
31.4
19.3
33.6
7.5
2.1
4.1
-4.3
-5
5.5
2
-1.1
1.3
0.7

Kasumiaruande rida

ResMed Inc. tulud muutusid võrreldes eelmise perioodiga 0.180%. RMD brutokasum on teatatud 2355.66. Ettevõtte tegevuskulud on 1203.66, mille muutus võrreldes eelmise aastaga on 17.543%. Kulud amortisatsioonikulud on 197.56, mis on 0.019% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 1203.66, mis näitab 17.543% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.132% kasvu võrreldes eelmise aastaga. Tegevustulu on 1131.87, mis näitab 0.132% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 0.152%. Eelmise aasta puhaskasum oli 897.56.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

4444.8842233578.13196.8
2957
2606.6
2340.2
2066.7
1838.7
1678.9
1555
1514.5
1368.5
1243.1
1092.4
920.7
835.4
716.3
607
425.5
339.3
273.6
204.1
155.2
115.6
88.6
66.5
49.2
34.6
23.5
13.9
7.7

income-statement-row.row.cost-of-revenue

1898.921867.31553.81357.7
1239.2
1070
978
865
772.2
667.5
565.2
573.8
547.8
501.8
436.9
366.9
341.6
331.8
230.1
150.6
122.6
100.5
70.8
50.4
30.7
24.8
19.4
17.7
15.7
10.7
5.9
2.9

income-statement-row.row.gross-profit

2545.962355.72024.31839.1
1717.8
1536.6
1362.2
1201.7
1066.5
1011.4
989.8
940.7
820.7
741.3
655.5
553.8
493.8
384.5
376.9
274.9
216.7
173.1
133.2
104.8
84.9
63.8
47.1
31.5
18.9
12.8
8
4.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

304.81---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

9.36-5.731.131.1
30.1
74.9
-8.5
4.1
5
6.3
0.9
-2.2
8.5
10.1
8
7.1
9.8
6.9
7.1
1.4
0.5
0
104.7
0
6.2
4.6
3.7
2.6
1.3
0.6
0.3
0.2

income-statement-row.row.operating-expenses

1256.821203.71024926.7
908.7
900.6
801.9
745
625.2
596.2
578.4
585.8
525.3
473.4
412.1
360
348.4
294.3
244.5
167.1
131.4
105.8
184.1
61.1
51.7
38.5
29.8
23.2
15.2
10
6.7
4.1

income-statement-row.row.cost-and-expenses

3155.7430712577.82284.5
2148
1970.6
1779.9
1610
1397.4
1263.7
1143.6
1159.6
1073.1
975.2
849
726.9
690
626.2
474.6
317.7
254
206.3
254.9
111.4
82.5
63.3
49.2
40.9
30.9
20.7
12.6
7

income-statement-row.row.interest-income

32.9147.422.30.4
1
2.3
16.4
17.1
16.9
26.2
31.2
38.9
33.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

-54.73-47.4-22.324
40.4
36.2
28.4
28.2
11.2
5.8
6.1
6.4
4.8
0
10.1
10.1
10.1
1.3
1.3
-0.8
-3.2
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-76.52-3-39.8-20
-76.6
-60.4
-27
-26.8
-7.4
0.3
-5.4
-2.2
7.5
-11.7
3.2
-2.3
0.4
1.3
-1.1
-10.8
0.5
2.4
4
-15.6
0.2
-1.5
-1.3
2.8
3
1
0.5
0.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

9.36-5.731.131.1
30.1
74.9
-8.5
4.1
5
6.3
0.9
-2.2
8.5
10.1
8
7.1
9.8
6.9
7.1
1.4
0.5
0
104.7
0
6.2
4.6
3.7
2.6
1.3
0.6
0.3
0.2

income-statement-row.row.total-operating-expenses

-76.52-3-39.8-20
-76.6
-60.4
-27
-26.8
-7.4
0.3
-5.4
-2.2
7.5
-11.7
3.2
-2.3
0.4
1.3
-1.1
-10.8
0.5
2.4
4
-15.6
0.2
-1.5
-1.3
2.8
3
1
0.5
0.6

income-statement-row.row.interest-expense

-54.73-47.4-22.324
40.4
36.2
28.4
28.2
11.2
5.8
6.1
6.4
4.8
0
10.1
10.1
10.1
1.3
1.3
-0.8
-3.2
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

216.65197.6193.8208.9
180.2
264.2
120
112.2
86.8
73.1
9.7
10.1
14
10.1
8
7.1
59.5
48.1
41.6
29.1
17.9
12.6
10
8.4
6.2
4.6
3.7
2.6
1.3
0.6
0.3
0.2

income-statement-row.row.ebitda-caps

1508.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

1213.941131.91000.3903.7
809.7
579.3
541.8
425.8
429
409.2
405.1
354.8
294.4
266.9
240.4
190.3
143
90.2
131.3
97.4
85.4
67.2
-51.2
26
33.1
25.3
17.3
8.3
3.7
2.8
1.3
0.7

income-statement-row.row.income-before-tax

1183.871101.7960.5883.7
733.1
518.8
521.3
418.7
439.6
435.9
431.1
385.1
331.9
303.7
260.6
201.7
157.9
98
133.4
96.6
84.7
67.1
54.6
27.3
34.2
24.6
16.1
11.1
6.6
3.7
1.8
1.2

income-statement-row.row.income-tax-expense

225.49204.1181409.2
111.4
114.3
205.7
76.5
87.2
83
85.8
78
77.1
76.7
70.5
55.2
47.6
31.7
45.2
31.8
27.4
21.4
17.1
15.7
11.9
8.5
5.5
3.6
2.1
0.9
0.6
0.4

income-statement-row.row.net-income

958.38897.6779.4474.5
621.7
404.6
315.6
342.3
352.4
352.9
345.3
307.1
254.8
227
190.1
146.4
110.3
66.3
88.2
64.8
57.3
45.7
37.5
11.6
22.2
16.1
10.6
7.5
4.5
2.8
1.2
0.8
Sarnased aktsiad
Sind võib huvitada ka:
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
12.14 CNY
SHZ
137310.KS
SD BioSensor, Inc.
10550 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
7.42 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.46 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
ALC.SW
Alcon Inc..
71.2 CHF
SIX
TARSONS.NS
Tarsons Products Limited.
454.25 INR
NSE
SDI.AX
SDI Limited.
0.86 AUD
ASX
OMIC
Singular Genomics Systems, Inc..
0.4 USD
NASDAQ

Korduma kippuv küsimus

Mis on ResMed Inc. (RMD) koguvara?

ResMed Inc. (RMD) koguvara on 6751708000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 2359781000.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.573.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 7.290.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.216.

Mis on ettevõtte kogutulu?

Kogutulu on 0.273.

Mis on ResMed Inc. (RMD) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 897556000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 1579908000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 1203665000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 237910000.000.